Literature DB >> 2965001

Beta-endorphin-like immunoreactivity in normal mucosa, muscle layer, adenocarcinoma, and polyp of the colon.

A Tari1, Y Miyachi, K Sumii, K Haruma, M Yoshihara, G Kajiyama, A Miyoshi.   

Abstract

beta-Endorphin-like immunoreactivity was detected in the mucosa and muscle layer of normal colon, adenocarcinomas derived from the colon mucosa, and colon polyps which were histologically confirmed to be adenoma without a focus of carcinoma or with in situ carcinoma. The contents of beta-endorphin-like immunoreactivity in adenocarcinomatous tissue (11.94 +/- 1.77 pmol/g wet wt) and colon polyps without focus of carcinoma (10.71 +/- 1.50 pmol/g wet wt) were found to be significantly higher than those in the mucosal layer (6.86 +/- 0.64 pmol/g wet wt) and muscle layer (8.30 +/- 0.68 pmol/g wet wt) of normal colon. These data suggest that the production of beta-endorphin-like immunoreactivity is specifically increased in some adenocarcinomas and adenomatous polyps and may be related to the alteration of bowel habits. Gel exclusion chromatography of beta-endorphin-like immunoreactivity revealed three peaks corresponding to beta-endorphin, beta-lipotropin, and an immunoreactive form between the two. In the mucosal layer and muscle layer of the colon, a broad major peak was eluted at the position of beta-endorphin, and minor peaks were eluted at the position of beta-lipotropin and between beta-endorphin and beta-lipotropin. In adenocarcinoma and polyp, the peak size corresponding to authentic beta-lipotropin was greater than that of beta-endorphin. This study demonstrated that beta-endorphin-like immunoreactivity existed at a high concentration in some colon adenocarcinomas and polyps whose elution patterns were different from those of normal colon tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965001     DOI: 10.1007/bf01536027

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat.

Authors:  R Elde; T Hökfelt; O Johansson; L Terenius
Journal:  Neuroscience       Date:  1976-08       Impact factor: 3.590

2.  Enkephalin inhibits firing of myenteric neurones.

Authors:  R A North; J T Williams
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

3.  Elevated immunoreactive beta-endorphin level in ventricular fluid after analgesic electrical stimulation of posteromedial hypothalamus.

Authors:  A Tari; Y Miyachi; K Tanaka; A Miyoshi; Y Mayanagi; A Mizuchi
Journal:  Endocrinol Jpn       Date:  1983-12

4.  Enkephalins in large bowel malignancy and in acute appendicitis.

Authors:  W G Davis; W P Tormey; P V Delaney
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

5.  Beta-endorphinlike immunoreactivity and somatostatinlike immunoreactivity in normal gastric mucosa, muscle layer, and adenocarcinoma.

Authors:  A Tari; Y Miyachi; M Hide; K Sumii; G Kajiyama; E Tahara; K Tanaka; A Miyoshi
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

6.  Radioimmunoassay detection of endorphins from long-term culture of human pituitary tumour cells.

Authors:  B Sharp; S Melmed; R Goldberg; H E Carlson; S Refetoff; J M Hershman
Journal:  Acta Endocrinol (Copenh)       Date:  1982-02

7.  Enkephalin-like immunoreactivity in the human gastrointestinal tract.

Authors:  J M Polak; S R Bloom; S N Sullivan; P Facer; A G Pearse
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

  7 in total
  1 in total

1.  Release of endogenous opioids from duodenal enteroendocrine cells requires Trpm5.

Authors:  Zaza Kokrashvili; Deniliz Rodriguez; Valeriya Yevshayeva; Hang Zhou; Robert F Margolskee; Bedrich Mosinger
Journal:  Gastroenterology       Date:  2009-03-09       Impact factor: 22.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.